The antiparkinsonian activity of dopamine agonists and their interaction with central dopamine receptor subtypes
- PMID: 1978511
The antiparkinsonian activity of dopamine agonists and their interaction with central dopamine receptor subtypes
Similar articles
-
[Dopamine agonists in the therapy of parkinson syndrome].Nervenarzt. 1985 Feb;56(2):69-81. Nervenarzt. 1985. PMID: 3982566 German. No abstract available.
-
Dopamine agonists, sleep disorders, and driving in Parkinson's disease.Adv Neurol. 2003;91:343-9. Adv Neurol. 2003. PMID: 12442692 Review. No abstract available.
-
Medications for Parkinson's disease.Neurologist. 2007 Nov;13(6):387-8. doi: 10.1097/NRL.0b013e318158e47d. Neurologist. 2007. PMID: 18090719 No abstract available.
-
Early dopamine agonist therapy in Parkinson's disease.Mov Disord. 1989;4 Suppl 1:S86-94. doi: 10.1002/mds.870040511. Mov Disord. 1989. PMID: 2566915 No abstract available.
-
New insights in Parkinson's disease therapy: can levodopa-induced dyskinesia ever be manageable.Adv Neurol. 2003;91:51-64. Adv Neurol. 2003. PMID: 12442663 Review. No abstract available.
Cited by
-
Modeling and imaging cardiac sympathetic neurodegeneration in Parkinson's disease.Am J Nucl Med Mol Imaging. 2014 Mar 20;4(2):125-59. eCollection 2014. Am J Nucl Med Mol Imaging. 2014. PMID: 24753981 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical